senescence Clinical Trials

10 recruitingLast updated: May 13, 2026

There are 10 actively recruiting senescence clinical trials across 8 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3. Top locations include Aalborg, North Denmark, Denmark, Aarhus, Central Jutland, Denmark, Berlin, Germany. Updated daily from ClinicalTrials.gov.


senescence Trials at a Glance

10 actively recruiting trials for senescence are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Aalborg, Aarhus, and Berlin. Lead sponsors running senescence studies include Hospices Civils de Lyon, Intervene Immune, Inc., and Charite University, Berlin, Germany.

Browse senescence trials by phase

Treatments under study

About senescence Clinical Trials

Looking for clinical trials for senescence? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new senescence trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about senescence clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting
Not Applicable

Skin Inflammation in (Peri)Menopause: A Probiotic Intervention Proof of Concept Trial

Skin healthRosaceaMenopause+5 more
King's College London30 enrolled1 locationNCT07341087
Recruiting
Not Applicable

Interferon Reference for Older People - REFIPA Study

ImmunosenescenceUninfected Older
Hospices Civils de Lyon62 enrolled1 locationNCT07239830
Recruiting
Phase 1Phase 2

Effect of a Daily Supplement on Plasma PAI-1 Levels

Endothelial DysfunctionAgingsenescence
University of California, Los Angeles35 enrolled2 locationsNCT07469475
Recruiting
Not Applicable

VITAL: Vaccination, Immunity, Time-restricted Eating, Aging and Lifestyle

VaccinationImmunosenescenceMetabolism
Charite University, Berlin, Germany24 enrolled1 locationNCT07000708
Recruiting

Biobank and Brain Health in Bordeaux.

DementiaBrain DiseasesDepression+12 more
University Hospital, Bordeaux2,050 enrolled1 locationNCT05322343
Recruiting

Multiparametric MRI in a Prospective Cohort of Living Kidney Donors, Recipients, and Healthy Controls: Correlations With Markers of Renal Function, Fibrosis and Ageing

Kidney TransplantationLiving DonorsMultiparametric Magnetic Resonance Imaging+2 more
Patrick Schjelderup96 enrolled2 locationsNCT06210555
Recruiting
Not Applicable

The Impact of Nicotinamide Mononucleotide Sustained-release Tablets on Immunosenescence and Metablism in Middle-aged and Elderly Individuals With Metabolic Disorders.

ImmunosenescenceMetabolism
Qing Su126 enrolled1 locationNCT06907329
Recruiting
Phase 2

Thymus Regeneration, Immunorestoration, and Insulin Mitigation Extension Trial

ImmunosenescenceEpigenetic Aging
Intervene Immune, Inc.85 enrolled1 locationNCT04375657
Recruiting

Senescent Endometrial Cells in Patients with Thin Endometrial Lining

Asherman's SyndromeThin Endometrial LiningCell Senescence
Trio Fertility100 enrolled1 locationNCT06450301
Recruiting
Phase 3

New alternative therapeutical strategies in early senescence and immunosenescence

Immunosenescence
University of Medicine and Pharmacy "Victor Babes" Timisoara400 enrolled1 locationACTRN12612001159842